WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

UnitedHealth, FTC reach tentative settlement pact over insulin prices

UnitedHealth (UNH) Group subsidiaries OptumRx and Emisar Pharma Services and the Federal Trade Commission have reached an agreement that would s...

Raccontata damarkets.businessinsider.comfiercehealthcare.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
markets.businessinsider.comStai leggendo16 h fa

UnitedHealth, FTC reach tentative settlement pact over insulin prices

UnitedHealth (UNH) Group subsidiaries OptumRx and Emisar Pharma Services and the Federal Trade Commission have reached an agreement that would s...

originale
fiercehealthcare.com14 h fa

Optum Rx, FTC posed for settlement in insulin pricing case

The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court documents suggest the agency has reached an agreement with Op | The Federal Trade…

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 12 giugno 2026·markets.businessinsider.com

    UnitedHealth, FTC reach tentative settlement pact over insulin prices

    UnitedHealth (UNH) Group subsidiaries OptumRx and Emisar Pharma Services and the Federal Trade Commission have reached an agreement that would s...

  2. venerdì 12 giugno 2026·fiercehealthcare.com

    Optum Rx, FTC posed for settlement in insulin pricing case

    The Federal Trade Commission may be winding down its ongoing insulin case against the three largest pharmacy benefit managers, as court documents suggest the agency has reached an…